MTOR and early-onset autosomal dominant Alzheimer disease: mTOR inhibitors are currently the only pharmacological treatment shown to extend lifespan in model organisms [53,54,55], and mTOR signaling has been directly implicated in age-associated disorders such as Alzheimer’s disease [56].